Harvey Investment Company’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.9M Sell
49,209
-875
-2% -$491K 2.82% 12
2026
Q1
$28.1M Sell
50,084
-2,255
-4% -$1.45M 3.09% 9
2025
Q4
$35.4M Sell
52,339
-60
-0.1% -$40.9K 3.77% 6
2025
Q3
$33.5M Sell
52,399
-244
-0.5% -$148K 3.57% 6
2025
Q2
$28.2M Buy
52,643
+150
+0.3% +$71.7K 3.1% 10
2025
Q1
$22M Hold
52,493
2.45% 15
2024
Q4
$21.7M Sell
52,493
-650
-1% -$285K 2.51% 15
2024
Q3
$26.8M Sell
53,143
-30
-0.1% -$14.6K 3.03% 12
2024
Q2
$25.9M Sell
53,173
-235
-0.4% -$118K 3.1% 11
2024
Q1
$28.8M Hold
53,408
3.25% 9
2023
Q4
$29.6M Sell
53,408
-50
-0.1% -$23.5K 3.59% 9
2023
Q3
$23.4M Buy
53,458
+2,235
+4% +$1.11M 3.06% 9
2023
Q2
$25.7M Sell
51,223
-13,315
-21% -$6.38M 3.36% 8
2023
Q1
$32.3M Hold
64,538
4.01% 6
2022
Q4
$26.3M Sell
64,538
-87
-0.1% -$33.8K 3.4% 7
2022
Q3
$21.1M Buy
64,625
+10
+0% +$3.67K 3.05% 11
2022
Q2
$22.7M Sell
64,615
-745
-1% -$304K 3.19% 9
2022
Q1
$35.8M Sell
65,360
-1,211
-2% -$637K 4.38% 5
2021
Q4
$43.8M Sell
66,571
-2,125
-3% -$1.33M 5.08% 2
2021
Q3
$42.7M Sell
68,696
-1,460
-2% -$981K 5.56% 2
2021
Q2
$44.3M Sell
70,156
-1,196
-2% -$660K 5.84% 2
2021
Q1
$34.9M Sell
71,352
-2,750
-4% -$1.38M 4.97% 4
2020
Q4
$37M Sell
74,102
-163
-0.2% -$72.9K 5.22% 4
2020
Q3
$29.2M Sell
74,265
-53
-0.1% -$19.6K 4.56% 6
2020
Q2
$24.5M Sell
74,318
-395
-0.5% -$114K 4.16% 6
2020
Q1
$18.1M Sell
74,713
-800
-1% -$209K 3.55% 9
2019
Q4
$19.7M Hold
75,513
3.04% 11
2019
Q3
$20.5M Sell
75,513
-80
-0.1% -$22.3K 3.4% 9
2019
Q2
$20.8M Sell
75,593
-5,282
-7% -$1.3M 3.51% 9
2019
Q1
$18.1M Sell
80,875
-3,697
-4% -$763K 3.11% 14
2018
Q4
$15.7M Sell
84,572
-1,420
-2% -$291K 3.03% 12
2018
Q3
$21.5M Sell
85,992
-4,762
-5% -$1.16M 3.72% 8
2018
Q2
$19.8M Sell
90,754
-6,616
-7% -$1.36M 3.65% 8
2018
Q1
$18.6M Sell
97,370
-4,001
-4% -$738K 3.44% 11
2017
Q4
$15.9M Sell
101,371
-3,610
-3% -$568K 2.88% 12
2017
Q3
$16.3M Sell
104,981
-3,475
-3% -$549K 3.22% 9
2017
Q2
$17.5M Sell
108,456
-1,700
-2% -$276K 3.55% 8
2017
Q1
$17M Sell
110,156
-25,276
-19% -$3.48M 3.52% 8
2016
Q4
$15.9M Sell
135,432
-1,490
-1% -$170K 3.35% 9
2016
Q3
$15.4M Sell
136,922
-1,809
-1% -$191K 3.28% 9
2016
Q2
$12.9M Sell
138,731
-234
-0.2% -$20.1K 2.8% 11
2016
Q1
$10.9M Hold
138,965
2.42% 17
2015
Q4
$10.1M Sell
138,965
-300
-0.2% -$21.4K 2.32% 17
2015
Q3
$10.3M Sell
139,265
-800
-0.6% -$57.3K 2.49% 12
2015
Q2
$8.98M Buy
140,065
+115
+0.1% +$7.96K 2.09% 20
2015
Q1
$10.8M Sell
139,950
-67,210
-32% -$5.23M 2.57% 12
2014
Q4
$15.4M Sell
207,160
-700
-0.3% -$49.1K 3.57% 8
2014
Q3
$12.2M Hold
207,860
3.09% 8
2014
Q2
$13.9M Hold
207,860
3.45% 8
2014
Q1
$12.6M Hold
207,860
3.25% 7
2013
Q4
$11.1M Sell
207,860
-1,600
-0.8% -$84.2K 2.93% 7
2013
Q3
$10.4M Sell
209,460
-1,000
-0.5% -$48.1K 2.95% 8
2013
Q2
$9.44M Buy
+210,460
New +$9.2M 2.83% 9

Other funds holding IDXX

Harvey Investment Company's IDXX Position: Q2 2026 in Review

Harvey Investment Company reduced its Idexx Laboratories (IDXX) stake by 1.7% in Q2 2026, selling an estimated $491K and leaving 49,209 shares worth $25.9M. The position accounts for 2.82% of the portfolio, ranked #12.

Harvey Investment Company first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $44.3M in Q2 2021. 418 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Harvey Investment Company held 49,209 shares of Idexx Laboratories worth $25.9M as of Q2 2026.
  • Harvey Investment Company sold 875 Idexx Laboratories shares in Q2 2026, an estimated $491K.
  • Idexx Laboratories made up 2.82% of Harvey Investment Company's portfolio in Q2 2026, its #12 holding.
  • Harvey Investment Company first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Harvey Investment Company's Idexx Laboratories position peaked at $44.3M in Q2 2021.
  • 418 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Harvey Investment Company's 13F filing for Q2 2026, filed 22 Jul 2026.